Navigation Links
Mylan Reports Adjusted Diluted EPS of $0.45 for the Quarter, a 36% Increase over Prior Year Quarter; and $1.61 for the Year, a 24% Increase over Prior Year
Date:2/24/2011

AAP financial measures and the reconciliation of non-GAAP measures to their most closely applicable GAAP measure set forth below and should consider non-GAAP measures only as a supplement to, not as a substitute for or as a superior measure to, measures of financial performance prepared in accordance with GAAP.

Below is a reconciliation of GAAP net earnings attributable to Mylan Inc. and diluted GAAP EPS to adjusted net earnings attributable to Mylan Inc. and adjusted diluted EPS for the quarter and years ended December 31, 2010 and 2009 (in millions, except per share amounts): Three months ended December 31,Year ended December 31,2010200920102009GAAP net earnings attributable to Mylan Inc. and diluted GAAP EPS

$
2.6

$
.01$
4.1

$
.01$
223.6

$
.68$
93.5

$
.30Purchase accounting related amortization (a)

91.672.4309.2282.5Litigation settlements, net

112.8114.2127.1225.7Interest, primarily amortization of debt discount, net

18.011.260.042.9Financing related costs

22.4-37.4-Acquisition related costs(b)

0.2-12.7Integration & other special items (c)

18.740.868.571.6Tax effect of the above items (d)

(86.9)(135.0)(252.8)(272.5)Preferred dividend

17.3

(e) 34.8

(e) 121.6

(e) 139.0

(e) Adjusted net earnings attributable to Mylan Inc. and adjusted diluted EPS

$
96.7

$
.45$
42.5

$
.33$
707.3

$
.61$
582.7

$
.30(a)  This amount is included in cost of sales.

(b)  This amount is included in SG&A.  

(c)  Integration and other special items include charges related to the integration of acquired businesses as well as certain restructuring items, losses on sales of certain non-operating assets, severance and employee benefit related charges.

-  For the three months ended December 31, 2010, $4.0 million of these expenses, ne
'/>"/>

SOURCE Mylan Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related biology technology :

1. Mylan Confirms First-to-File Patent Challenge Relating to Lescol(R)
2. Mylan Reports Adjusted Diluted EPS of $0.23 for the Quarter Ended Sept. 30, 2008
3. Cephalon and Eurand File Patent Infringement Lawsuit Against Mylan Pharmaceuticals and Barr Pharmaceuticals
4. Shire Receives FOSRENOL Paragraph IV Notice Letters from Barr Laboratories and Mylan
5. Mylan Reports Adjusted Diluted EPS of $0.26 for the Quarter Ended Dec. 31, 2008, and Adjusted Diluted EPS of $0.80 for the Year Ended Dec. 31, 2008
6. Shire Files Lawsuit Against Mylan for Infringement of FOSRENOL(R) (Lanthanum Carbonate) Patent
7. Mylan Confirms Four First-to-File Challenges
8. Mylans Matrix Receives First Tentative FDA Approval Under PEPFAR for Generic Truvada(R)
9. Mylans Matrix Selected by the Clinton HIV/AIDS Initiative and UNITAID as the Primary Supplier of Five Second-Line and Seven Pediatric HIV/AIDS Treatments
10. Mylan Receives Tentative FDA Approval for Generic Version of Singulair(R)
11. Mylan Again Calls for an End to Authorized Generics During 180-Day Exclusivity Period
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... Miami, FL (PRWEB) May 22, 2013 A ... effects of probiotics on athletes to find that those who ... percent longer. The results from the study showed that in ... Probiotic Action, known for their adult acne treatment ... acne, and how it may help their skin condition. ...
(Date:5/21/2013)... , May 21, 2013  On May ... FCN ), the global business advisory firm dedicated ... value (the "Company"), announced that it has combined ... were formerly included within the Corporate Finance/Restructuring segment ... segment to form a single integrated practice whose ...
(Date:5/21/2013)... by George Washington University Professor Tianshu Li provide ... small droplets is strongly size-dependent, an important conclusion ... formation of ice at the nanoscale is a ... has important implications for climate research and other ... supercooled water is generally initiated by a process ...
(Date:5/21/2013)... May 21, 2013 Clinverse, ... company for clinical trials, announced today it has ... LLC. Clinverse’s ClinPay® FLS eClinical commerce platform ... process. SpendMD ™, Aggregate Spend Solutions’ ... for tracking and reporting transfer of value at ...
Breaking Biology Technology:Adult Acne Treatment, Probiotic Action Shares Insight on New Findings Between Probiotics and Heat Tolerance, and What It Means for Acne Sufferers 2FTI Consulting Releases Realigned Segment Information Reflecting Newly Combined Health Solutions Practice 2Study led by GW professor provides better understanding of water's freezing behavior at nanoscale 2Clinverse, Inc. Announces Strategic Alliance with Aggregate Spend Solutions, LLC 2Clinverse, Inc. Announces Strategic Alliance with Aggregate Spend Solutions, LLC 3
... of Complex Arrhythmias Achieved Approval Considered ... Jan. 15 Stereotaxis, Inc. (Nasdaq:,STXS) announced today ... U.S. Food,and Drug Administration (FDA) has approved its ... ablation in the United States., "The long-awaited ...
... Detail Latest Cardiac Surgery Technology to be Held ... January 26th at 6:30 p.m. Eastern ... technology companies will host the first annual After Hours Event,on ... the yacht,"Princess Lady." The invitation-only event, immediately preceding the,largest meeting ...
... response to the,Federal Drug Administration,s announcement today that ... consumption, Smithfield Foods, Inc.,(NYSE: SFD ) reiterated ... produce meat products from cloned animals. The science ... leaders in our industry,we will continue to monitor ...
Cached Biology Technology:Stereotaxis Announces FDA Approval of Its Partnered Magnetic Irrigated Catheter 2Stereotaxis Announces FDA Approval of Its Partnered Magnetic Irrigated Catheter 3Five Medical Technology Companies Host Premier Event for Cardiothoracic Surgeons 2Five Medical Technology Companies Host Premier Event for Cardiothoracic Surgeons 3Five Medical Technology Companies Host Premier Event for Cardiothoracic Surgeons 4
(Date:5/21/2013)... "place" is increasingly being considered in the management ... new resource that can help them recognize and ... places in their lives. , Place-Based Conservation: ... co-edited by the Pacific Northwest Research Station,s Linda ... to conservation. The book is published by Springer ...
(Date:5/21/2013)... become most deadly when they metastasize and spread tumors ... it becomes very difficult for doctors to locate and ... at the University of Missouri have found a way ... wherever they may be in the body. Michael Lewis, ... of Veterinary Medicine, says being able to target secondary ...
(Date:5/21/2013)... largest scientific society, invites news media coverage of ... 2013, in Indianapolis, Ind. It will take place ... hotels. , With more than 7,100 presentations on ... astronomy to zoology ― the meeting will offer ... of spot news and feature possibilities. The topics ...
Breaking Biology News(10 mins):MU researchers develop radioactive nanoparticles that target cancer cells 2
... with genetic risk of bowel cancer has found that ... of insurance implications. "This indicates that people have ... decision to have potentially life saving genetic testing," says ... Melbourne,s Key Centre for Women,s Health in Society. ...
... mayapple may soon offer an alternative to an Asian ... its anti-cancer properties. The near-extinct Asian plant, Podophyllyum ... etoposide, the active ingredient in a drug used for ... is a cousin of the common mayapple weed found ...
... This is the conclusion of a study which has analyzed the ... 14 years. The decrease in this activity and the fall in ... 10%) are the reasons why the "war", in the sense of ... Researchers from the Mediterranean Institute for Advanced Studies (IMEDEA-CSIC) ...
Cached Biology News:Fear of insurance rejection deters potentially life saving genetic tests for bowel cancer 2Anticancer compound found in American mayapple 2The war against wildlife comes to an end in Southern Europe 2
A Highly Purified, Cost-Effective Taq DNA Polymerase...
Homo sapiens similar to Cytosolic acyl coenzyme A thioester hydrolase Antigen: Peptide...
... pending) is a protein based inhibitor of ... the most common and troublesome RNases including ... SUPERaseIn can be used in any application ... is ideal for in vitro transcription and ...
... Printer) is a revolutionary new approach ... Macroarray Analysis, developed in conjunction with ... compliments established protocols in resolving proteins ... isoelectric point and apparent molecular weight). ...
Biology Products: